NTHEX
Price
$3.62
Change
+$0.01 (+0.28%)
Updated
May 12 closing price
Net Assets
129.24M
VWEAX
Price
$5.45
Change
+$0.03 (+0.55%)
Updated
May 12 closing price
Net Assets
24.31B
Ad is loading...

NTHEX vs VWEAX

Header iconNTHEX vs VWEAX Comparison
Open Charts NTHEX vs VWEAXBanner chart's image
Northeast Investors Trust
Price$3.62
Change+$0.01 (+0.28%)
VolumeN/A
Net Assets129.24M
Vanguard High-Yield Corporate Adm
Price$5.45
Change+$0.03 (+0.55%)
VolumeN/A
Net Assets24.31B
NTHEX vs VWEAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NTHEX vs. VWEAX commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTHEX is a Buy and VWEAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VWEAX has more cash in the bank: 24.3B vs. NTHEX (129M). VWEAX pays higher dividends than NTHEX: VWEAX (6.30) vs NTHEX (5.42). NTHEX was incepted earlier than VWEAX: NTHEX (75 years) vs VWEAX (24 years). NTHEX (2.14) is less costly to investors than VWEAX (0.12). VWEAX is a more actively managed with annual turnover of: 37.00 vs. NTHEX (27.83). NTHEX has a lower initial minimum investment than VWEAX: NTHEX (1000) vs VWEAX (50000). NTHEX annual gain was more profitable for investors over the last year : 4.02 vs. VWEAX (1.85). NTHEX return over 5 years is better than : 28.96 vs. VWEAX (0.45).
NTHEXVWEAXNTHEX / VWEAX
Total Expense Ratio2.140.121,783%
Annual Report Gross Expense Ratio2.140.121,783%
Fund Existence75 years24 years-
Gain YTD0.2630.53449%
Front LoadN/AN/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets129M24.3B1%
Annual Yield % from dividends5.426.3086%
Returns for 1 year4.021.85218%
Returns for 3 years17.802.90613%
Returns for 5 years28.960.456,460%
Returns for 10 years16.1411.91136%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRHSX73.97N/A
N/A
T. Rowe Price Health Sciences
SDGZX117.59N/A
N/A
DWS Capital Growth R6
ISTAX23.09N/A
N/A
ICON Equity Investor
GMWEX11.90N/A
N/A
GuideMark® World ex-US Service
FHJMX41.29N/A
N/A
Fidelity Advisor Europe I